SetPoint Medical Starts Testing Unique Neuromodulation Device In Rheumatoid Arthritis Patients

 
• By Marion Webb

SetPoint Medical announced the launch of a multicenter clinical trial to test its vagus nerve stimulation system in rheumatoid arthritis patients who did not adequately respond to multiple biologic agents. Among the company's backers are Medtronic, Boston Scientific and GSK.

film x-ray both human's hands and arthritis at multiple joint (Gout,Rheumatoid)

More from Neurology

More from Device Area